VCMCVC Market Cap
Menu

Maven Clinic valuation, funding and investors

Maven Clinic works in digital health platform development, based in New York, United States. Founded in 2014, it has about 1,200 employees.

VALUATION · TODAY
$2.25B −15% after Series F
Range $1.19B – $2.59B · Grade B
TODAY
+12 MO
$1.00B
$2.00B
$3.00B
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $2.20M
Series A $11.0M
Series B $27.0M
Series C $45.0M
Series D $110M
Series E $90.0M
Series F $125M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,197 employees
+6%6m growth
+15%1y growth
+20%2y growth
500
1,000
1,500
Data from Jan 2021
TODAY
Predicted in 1 yr $1.91B −15% vs today
Predicted next raise $248M if a round comes
Winding-down probability 0%
Last round
Series F · $125M · Oct 2024
Valuation at last round
$1.70B
Headcount
1,197 · up
Grade
B
Founded
2014
How VCMC values companies →

Maven Clinic valuation today

VCMC values Maven Clinic at $2.3B today, with a range of $1.2B to $2.6B and a grade of B. The valuation starts from its last funding round, a Series F round in Oct 2024.

Valuation by date (162 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Maven Clinic: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2014$5.01M$1.83M – $13.8M$5.25M (+5%)before first round–unknownD0%
1 Feb 2014$5.03M$1.83M – $13.8M$5.28M (+5%)before first round–unknownD0%
1 Mar 2014$5.05M$1.84M – $13.9M$5.29M (+5%)before first round–unknownD0%
1 Apr 2014$5.07M$1.85M – $13.9M$5.32M (+5%)before first round–unknownD0%
1 May 2014$5.09M$1.85M – $14.0M$5.34M (+5%)before first round–unknownD0%
1 Jun 2014$5.11M$1.86M – $14.0M$5.36M (+5%)before first round–unknownD0%
1 Jul 2014$5.13M$1.87M – $14.1M$5.38M (+5%)before first round–unknownD0%
1 Aug 2014$5.15M$1.88M – $14.2M$5.40M (+5%)before first round–unknownD0%
1 Sep 2014$5.17M$1.88M – $14.2M$5.42M (+5%)before first round–unknownD0%
1 Oct 2014$5.19M$1.89M – $14.3M$5.44M (+5%)before first round–unknownD0%
1 Nov 2014$5.21M$1.90M – $14.3M$5.46M (+5%)before first round–unknownD0%
1 Dec 2014$5.23M$1.91M – $14.4M$5.48M (+5%)before first round–unknownD0%
1 Jan 2015$5.25M$1.91M – $14.4M$5.51M (+5%)before first round–unknownD0%
1 Feb 2015$5.28M$1.92M – $14.5M$5.53M (+5%)before first round–unknownD0%
1 Mar 2015$5.29M$1.93M – $14.5M$5.55M (+5%)before first round–unknownD0%
1 Apr 2015$5.32M$1.93M – $14.6M$5.57M (+5%)before first round–unknownD0%
10 Apr 2015$8.82M$5.78M – $26.8M$17.6M (+100%)after a round–unknownC0%
1 May 2015$9.18M$5.78M – $26.8M$17.6M (+92%)after a round–unknownC0%
1 Jun 2015$9.73M$5.78M – $26.8M$17.6M (+81%)after a round–unknownC0%
1 Jul 2015$10.3M$5.78M – $26.8M$17.6M (+71%)after a round–unknownC0%
1 Aug 2015$10.9M$5.78M – $26.8M$17.6M (+61%)after a round–unknownC0%
1 Sep 2015$11.6M$5.78M – $26.8M$17.6M (+52%)after a round–unknownC0%
1 Oct 2015$12.3M$5.78M – $26.8M$17.6M (+43%)after a round–unknownC0%
1 Nov 2015$13.0M$5.78M – $26.8M$17.6M (+35%)after a round–unknownC0%
1 Dec 2015$13.8M$5.78M – $26.8M$17.6M (+28%)after a round–unknownC0%
1 Jan 2016$14.6M$5.78M – $26.8M$17.6M (+20%)after a round–unknownC0%
1 Feb 2016$15.5M$5.78M – $26.8M$17.6M (+14%)after a round–unknownC0%
1 Mar 2016$16.4M$5.78M – $26.8M$17.6M (+8%)after a round–unknownC0%
1 Apr 2016$17.4M$5.78M – $26.8M$17.6M (+1%)after a round–unknownC0%
1 May 2016$17.6M$5.57M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Jun 2016$17.6M$5.29M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Jul 2016$17.6M$5.04M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Aug 2016$17.6M$4.79M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Sep 2016$17.6M$4.55M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Oct 2016$17.6M$4.33M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Nov 2016$17.6M$4.12M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Dec 2016$17.6M$3.92M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Jan 2017$17.6M$3.72M – $26.8M$17.6M (0%)after a round–unknownC0%
1 Feb 2017$17.6M$3.54M – $26.8M$17.6M (0%)after a round–unknownD0%
1 Mar 2017$17.6M$3.38M – $26.8M$17.6M (0%)after a round–unknownD0%
1 Apr 2017$17.6M$3.21M – $26.8M$17.6M (0%)after a round–unknownD0%
1 May 2017$17.6M$3.06M – $26.8M$17.6M (0%)after a round–unknownD0%
1 Jun 2017$17.6M$2.91M – $26.8M$17.6M (0%)after a round–unknownD0%
1 Jul 2017$17.6M$2.77M – $26.8M$17.6M (0%)after a round–unknownD0%
13 Jul 2017$52.5M$36.9M – $134M$94.3M (+80%)after a round–unknownC0%
1 Aug 2017$54.1M$36.9M – $134M$94.3M (+74%)after a round–unknownC0%
1 Sep 2017$56.9M$36.9M – $134M$94.3M (+66%)after a round–unknownC0%
1 Oct 2017$59.7M$36.9M – $134M$94.3M (+58%)after a round–unknownC0%
1 Nov 2017$62.7M$36.9M – $134M$94.3M (+50%)after a round–unknownC0%
1 Dec 2017$65.9M$36.9M – $134M$94.3M (+43%)after a round–unknownC0%
1 Jan 2018$69.2M$36.9M – $134M$94.3M (+36%)after a round–unknownC0%
1 Feb 2018$72.8M$36.9M – $134M$94.3M (+30%)after a round–unknownC0%
1 Mar 2018$76.1M$36.9M – $134M$94.3M (+24%)after a round–unknownC0%
1 Apr 2018$80.0M$36.9M – $134M$94.3M (+18%)after a round–unknownC0%
1 May 2018$84.0M$36.9M – $134M$94.3M (+12%)after a round–unknownC0%
1 Jun 2018$88.3M$36.9M – $134M$94.3M (+7%)after a round–unknownC0%
1 Jul 2018$92.6M$36.9M – $134M$94.3M (+2%)after a round–unknownC0%
1 Aug 2018$94.3M$35.7M – $134M$94.3M (0%)after a round–unknownC0%
1 Sep 2018$94.3M$34.0M – $134M$94.3M (0%)after a round–unknownC0%
27 Sep 2018$156M$110M – $332M$234M (+50%)after a round–unknownB0%
1 Oct 2018$157M$110M – $332M$234M (+49%)after a round–unknownB0%
1 Nov 2018$162M$110M – $332M$234M (+44%)after a round–unknownB0%
1 Dec 2018$168M$110M – $332M$234M (+39%)after a round–unknownB0%
1 Jan 2019$173M$110M – $332M$234M (+35%)after a round–unknownB0%
1 Feb 2019$180M$110M – $332M$234M (+30%)after a round–unknownB0%
1 Mar 2019$185M$110M – $332M$234M (+26%)after a round–unknownB0%
1 Apr 2019$192M$110M – $332M$234M (+22%)after a round–unknownB0%
1 May 2019$198M$110M – $332M$234M (+18%)after a round–unknownB0%
1 Jun 2019$205M$110M – $332M$234M (+14%)after a round–unknownB0%
1 Jul 2019$212M$110M – $332M$234M (+10%)after a round–unknownB0%
1 Aug 2019$219M$110M – $332M$234M (+6%)after a round–unknownB0%
1 Sep 2019$227M$110M – $332M$234M (+3%)after a round–unknownB0%
1 Oct 2019$234M$109M – $332M$234M (0%)after a round–unknownB0%
1 Nov 2019$234M$104M – $332M$234M (0%)after a round–unknownB0%
1 Dec 2019$234M$99.9M – $332M$234M (0%)after a round–unknownB0%
1 Jan 2020$234M$95.6M – $332M$234M (0%)after a round–unknownC0%
1 Feb 2020$234M$91.5M – $332M$234M (0%)after a round–unknownC0%
20 Feb 2020$353M$248M – $650M$458M (+30%)after a round–unknownB0%
1 Mar 2020$355M$248M – $650M$458M (+29%)after a round–unknownB0%
1 Apr 2020$363M$248M – $650M$458M (+26%)after a round–unknownB0%
1 May 2020$371M$248M – $650M$458M (+23%)after a round–unknownB0%
1 Jun 2020$379M$248M – $650M$458M (+21%)after a round–unknownB0%
1 Jul 2020$388M$248M – $650M$458M (+18%)after a round–unknownB0%
1 Aug 2020$396M$248M – $650M$458M (+16%)after a round–unknownB0%
1 Sep 2020$405M$248M – $650M$458M (+13%)after a round–unknownB0%
1 Oct 2020$414M$248M – $650M$458M (+11%)after a round–unknownB0%
1 Nov 2020$423M$248M – $650M$458M (+8%)after a round–unknownB0%
1 Dec 2020$433M$248M – $650M$458M (+6%)after a round–unknownB0%
1 Jan 2021$442M$248M – $650M$458M (+4%)after a round270unknownB0%
1 Feb 2021$452M$248M – $650M$458M (+1%)after a round270unknownB0%
1 Mar 2021$458M$244M – $650M$458M (0%)after a round270unknownB0%
1 Apr 2021$458M$233M – $650M$458M (0%)after a round270unknownB0%
1 May 2021$458M$223M – $650M$458M (0%)after a round270unknownB0%
1 Jun 2021$458M$213M – $650M$458M (0%)after a round270unknownB0%
1 Jul 2021$458M$204M – $650M$458M (0%)after a round270unknownB0%
1 Aug 2021$458M$194M – $650M$458M (0%)after a round270unknownC0%
18 Aug 2021$1.0B$869M – $1.5B$1.3B (+30%)after a round270unknownA0%
1 Sep 2021$1.0B$869M – $1.5B$1.3B (+29%)after a round270unknownA0%
1 Oct 2021$1.0B$869M – $1.5B$1.3B (+26%)after a round270unknownA0%
1 Nov 2021$1.1B$869M – $1.5B$1.3B (+23%)after a round270unknownA0%
1 Dec 2021$1.1B$869M – $1.5B$1.3B (+20%)after a round270unknownA0%
1 Jan 2022$1.1B$869M – $1.5B$1.3B (+18%)after a round270unknownA0%
1 Feb 2022$1.1B$869M – $1.5B$1.3B (+15%)after a round270unknownA0%
1 Mar 2022$1.2B$869M – $1.5B$1.3B (+13%)after a round270unknownA0%
1 Apr 2022$1.2B$869M – $1.5B$1.3B (+10%)after a round270unknownA0%
1 May 2022$1.2B$869M – $1.5B$1.3B (+8%)after a round530growingA0%
1 Jun 2022$1.2B$869M – $1.5B$1.3B (+6%)after a round530growingA0%
1 Jul 2022$1.3B$869M – $1.5B$1.3B (+3%)after a round530growingA0%
1 Aug 2022$1.3B$869M – $1.5B$1.3B (+1%)after a round530unknownA0%
1 Sep 2022$1.3B$850M – $1.5B$1.3B (0%)after a round530unknownA0%
1 Oct 2022$1.4B$1.2B – $2.0B$1.8B (+30%)after a round530unknownA0%
2 Oct 2022$1.4B$1.2B – $2.0B$1.8B (+30%)after a round530unknownA0%
1 Nov 2022$1.4B$1.2B – $2.0B$1.8B (+27%)after a round530unknownA0%
1 Dec 2022$1.4B$1.2B – $2.0B$1.8B (+24%)after a round530unknownA0%
1 Jan 2023$1.4B$1.2B – $2.0B$1.8B (+22%)after a round530unknownA0%
1 Feb 2023$1.5B$1.2B – $2.0B$1.8B (+19%)after a round740growingA0%
1 Mar 2023$1.5B$1.2B – $2.0B$1.8B (+17%)after a round740growingA0%
1 Apr 2023$1.5B$1.2B – $2.0B$1.8B (+14%)after a round740growingA0%
1 May 2023$1.6B$1.2B – $2.0B$1.8B (+12%)after a round740growingA0%
1 Jun 2023$1.6B$1.2B – $2.0B$1.8B (+9%)after a round740growingA0%
1 Jul 2023$1.6B$1.2B – $2.0B$1.8B (+7%)after a round740growingA0%
1 Aug 2023$1.7B$1.2B – $2.0B$1.8B (+4%)after a round740growingA0%
1 Sep 2023$1.7B$1.2B – $2.0B$1.8B (+2%)after a round740growingA0%
1 Oct 2023$1.8B$1.2B – $2.0B$1.8B (0%)after a round740growingA0%
1 Nov 2023$1.8B$1.2B – $2.1B$1.8B (0%)after a round900upA0%
1 Dec 2023$1.8B$1.2B – $2.1B$1.8B (0%)after a round900upB0%
1 Jan 2024$1.8B$1.1B – $2.1B$1.8B (0%)after a round900upB0%
1 Feb 2024$1.8B$1.1B – $2.1B$1.8B (0%)after a round900upB0%
1 Mar 2024$1.8B$1.1B – $2.1B$1.8B (0%)after a round900upB0%
1 Apr 2024$1.9B$1.1B – $2.1B$1.9B (0%)after a round980upB0%
1 May 2024$1.9B$1.1B – $2.1B$1.9B (0%)after a round980upB0%
1 Jun 2024$1.9B$1.1B – $2.1B$1.9B (0%)after a round980upB0%
1 Jul 2024$1.9B$1.1B – $2.1B$1.9B (0%)after a round980upB0%
1 Aug 2024$1.9B$783M – $2.1B$1.9B (0%)after a round980flatB0%
1 Sep 2024$1.9B$1.1B – $2.2B$1.9B (0%)after a round1,000upB0%
1 Oct 2024$1.9B$1.0B – $2.2B$1.9B (0%)after a round1,000upB0%
9 Oct 2024$1.7B$1.5B – $2.5B$2.2B (+30%)after a round1,000upA0%
1 Nov 2024$1.7B$1.5B – $2.5B$2.2B (+28%)after a round1,000upA0%
1 Dec 2024$1.8B$1.5B – $2.5B$2.2B (+25%)after a round1,100upA0%
1 Jan 2025$1.8B$1.5B – $2.5B$2.2B (+22%)after a round1,100upA0%
1 Feb 2025$1.8B$1.5B – $2.5B$2.2B (+20%)after a round1,100upA0%
1 Mar 2025$1.9B$1.5B – $2.5B$2.2B (+17%)after a round1,100upA0%
1 Apr 2025$1.9B$1.5B – $2.5B$2.2B (+15%)after a round1,100upA0%
1 May 2025$2.0B$1.5B – $2.5B$2.2B (+12%)after a round1,100upA0%
1 Jun 2025$2.0B$1.5B – $2.5B$2.2B (+10%)after a round1,100upA0%
1 Jul 2025$2.1B$1.5B – $2.5B$2.2B (+7%)after a round1,100upA0%
1 Aug 2025$2.1B$1.5B – $2.5B$2.2B (+5%)after a round1,040flatA0%
1 Sep 2025$2.1B$1.5B – $2.5B$2.2B (+3%)after a round1,041flatA0%
1 Oct 2025$2.2B$1.5B – $2.5B$2.2B (0%)after a round1,041flatA0%
1 Nov 2025$2.2B$1.4B – $2.5B$2.2B (0%)after a round1,041flatA0%
1 Dec 2025$2.2B$1.4B – $2.5B$2.2B (0%)after a round1,073flatB0%
1 Jan 2026$2.2B$1.3B – $2.5B$2.2B (0%)after a round1,073flatB0%
1 Feb 2026$2.2B$1.2B – $2.5B$2.2B (0%)after a round1,073flatB0%
1 Mar 2026$2.2B$1.2B – $2.6B$2.2B (0%)after a round1,133flatB0%
1 Apr 2026$2.2B$1.1B – $2.6B$2.2B (0%)after a round1,133flatB0%
1 May 2026$2.2B$1.1B – $2.6B$2.2B (0%)after a round1,133flatB0%
1 Jun 2026$2.2B$1.0B – $2.6B$2.2B (0%)after a round1,133flatB0%
1 Jul 2026$2.2B$1.4B – $2.6B$2.2B (0%)after a round1,178upB0%
1 Aug 2026$2.2B$1.3B – $2.6B$2.2B (0%)after a round1,178upB0%
1 Sep 2026$2.2B$1.3B – $2.6B$2.2B (0%)after a round1,178upB0%
1 Oct 2026$2.3B$1.3B – $2.6B$2.3B (0%)after a round1,197upB0%
24 Oct 2026$2.3B$1.2B – $2.6B$1.9B (-15%)after a round1,197upB0%

Key facts about Maven Clinic

Founded
2014
Headquarters
New York, United States
Employees
about 1,200 +15% in a year
Total raised
$410M
Funding rounds
7
Last round
Series F Oct 2024

Maven Clinic was founded in 2014 by Kate Ryder.

Maven Clinic funding history

Maven Clinic has 7 funding rounds on record, from Apr 2015 to Oct 2024, $410M in total. The latest disclosed valuation is $1.70B post-money (Series F, Oct 2024).

  1. Series F 8 Oct 2024

    Led by StepStone Group; with General Catalyst, Sequoia Capital, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, Lux Capital.

    Sources: mavenclinic.com, prnewswire.com, globalwomanleader.com and 1 more

    $125M

    $1.70B post-money

  2. Series E 1 Oct 2022

    Led by General Catalyst; with Lux Capital, Oak HC/FT, Sequoia Capital.

    Sources: codametrix.com, prnewswire.com

    $90M

    $1.35B post-money

  3. Series D 17 Aug 2021

    Led by Dragoneer Investment Group, Lux Capital; with BOND, Sequoia Capital, Oak HC/FT, Icon Ventures. Individuals: Oprah Winfrey.

    Sources: mavenclinic.com, prnewswire.com

    $110M

    $1.00B post-money

  4. Series C 19 Feb 2020

    Led by Icon Ventures; with Sequoia Capital, Oak HC/FT, Spring Mountain Capital, Female Founders Fund, Harmony Partners.

    Sources: mavenclinic.com, prnewswire.com, mobihealthnews.com and 2 more

    $45M

  5. Series B 26 Sep 2018

    Led by Sequoia Capital, Oak HC/FT; with Spring Mountain Capital, 14W, Female Founders Fund.

    Sources: mavenclinic.com, prnewswire.com, mobihealthnews.com and 1 more

    $27M

  6. Series A 12 Jul 2017

    Led by Spring Mountain Capital; with 14W, Female Founders Fund, DGNL, Colle Capital, 8VC, BoxGroup.

    Sources: mavenclinic.com, mavenclinic.com, jonesday.com

    $11M

  7. Seed 9 Apr 2015

    With Great Oaks Venture Capital, BoxGroup, F Cubed. Individuals: Matt Mullenweg, Susan Lyne, Thomas Lehrman.

    Sources: techcrunch.com, medcitynews.com

    $2.2M

Maven Clinic investors

18 investors have backed Maven Clinic; Oak HC/FT, Sequoia Capital and Icon Ventures and 5 more led at least one round.

What Maven Clinic does

Maven Clinic works in health care services, with 15 recorded offerings and customers in healthcare.

Maven Clinic is a United States company that operates a digital health platform and virtual clinic engaged in women's and family healthcare. The company provides telemedicine services in areas such as fertility, adoption, surrogacy, pregnancy, parenting, and menopause support, as well as maternity and newborn care, pediatric care, and menopause and midlife support. Maven Clinic also offers clinical research and benefit management solutions, and collaborates with a network of healthcare providers to deliver its services in multiple languages. The company serves employers, health plans, consultants, and individuals, and is supported by a virtual care network and a clinical research institute.

Description from Veridion's company data.

Products and services

  • Digital Health Platform Development
  • Virtual Clinic Services
  • Fertility and Reproductive Health Services
  • Adoption and Surrogacy Support Services
  • Pregnancy and Maternity Care Services
  • Parenting and Pediatric Care Services
  • Menopause and Midlife Health Services
  • Maternal Mental Health Support Services
  • Clinical Benefit Management Solutions
  • Virtual Care Network Services
  • Clinical Research and Impact Studies
  • Healthcare Provider Network Expansion
  • Multilingual Healthcare Services
  • Workforce Diversity and Inclusion Consulting
  • Healthcare Cost Reduction Consulting

Markets

  • Healthcare

Technology

  • Telemedicine for Virtual Healthcare

Business model

  • Business-to-Business
  • Business-to-Consumer
  • Service Provider
  • Healthcare

Industry codes (NAICS)

  • 621111 Offices of Physicians (except Mental Health Specialists) 100% match

Questions about Maven Clinic

What is Maven Clinic worth?

Valuation $2.3B (range $1.2B to $2.6B), as of 24 Oct 2026. The last disclosed valuation was $1.70B (Series F, Oct 2024).

Has Maven Clinic raised money?

Maven Clinic has 7 funding rounds on record, from Apr 2015 to Oct 2024, $410M in total. The latest disclosed valuation is $1.70B post-money (Series F, Oct 2024).

Who has invested in Maven Clinic?

Oak HC/FT, Sequoia Capital, Icon Ventures, Lux Capital, Spring Mountain Capital and Dragoneer Investment Group, and 12 more. Lead investors include Oak HC/FT, Sequoia Capital, Icon Ventures and Lux Capital.

How many people work at Maven Clinic?

About 1,200, up 15% over the last year. Headcount grew from 270 in Jan 2021 to 1,197 in Sep 2026.

What does Maven Clinic do?

Maven Clinic works in health care services, with 15 recorded offerings and customers in healthcare. Its main offerings are digital health platform development, virtual clinic services and fertility and reproductive health services.

When was Maven Clinic founded, and where is it based?

Maven Clinic was founded in 2014 and is based in New York, United States. It has about 1,200 employees, up 15% over the last year.